In March 2020, a severe respiratory syndrome developed in a cat, 1 week after its owner received positive test results for severe acute respiratory syndrome coronavirus 2. Viral RNA was detected in the cat's nasopharyngeal swab samples and vomitus or feces; immunoglobulin against the virus was found in convalescent-phase serum. Human-to-cat transmission is suspected.
In March 2020, a severe respiratory syndrome developed in a cat, 1 week after its owner received positive test results for severe acute respiratory syndrome coronavirus 2. Viral RNA was detected in the cat's nasopharyngeal swab samples and vomitus or feces; immunoglobulin against the virus was found in convalescent-phase serum. Human-to-cat transmission is suspected.
We report the investigation of illness andinfection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in a household cat in Belgium (1).
The cat was a female domestic shorthair, »15 years of age, that had been adopted
2 years earlier. The owner considered the cat to have been healthy since adoption,
although it had never been assessed by a veterinarian. In February 2020, the owner took
part in a 7-day tour to a mountain resort in Lombardy, Italy. The day after returning
home, March 2, the owner felt suddenly too short of breath to conduct normal activities.
As a precautionary measure, the family doctor decided to take a deep oropharyngeal swab
sample and asked the patient to remain at home until the test result was reported. Over
the next 10 days, the patient experienced a series of general, respiratory, and then
digestive symptoms consistent with the clinical signs associated with coronavirus
disease (COVID-19) (Figure). On March 6, the swab
sample was declared positive for the SARS-CoV-2 genome, and home quarantine was extended
until the end of March.
Figure 7
Timeline of disease course for human and cat with SARS-CoV-2 infection, by days
from illness onset according to the cat owner, Belgium, February 22–March
25, 2020. NA, not available; ND, not determined; SARS-CoV-2, severe acute
respiratory syndrome coronavirus 2.
Timeline of disease course for human andcat with SARS-CoV-2 infection, by days
from illness onset according to the cat owner, Belgium, February 22–March
25, 2020. NA, not available; ND, not determined; SARS-CoV-2, severe acute
respiratory syndrome coronavirus 2.During that time, the patient’s household cat was asymptomatic (Video 1). However, 1 week later, the cat suddenly
demonstrated clinical signs; the cat was found prostrated andvomiting in her litter,
then showed pronounced lethargy, poor appetite to anorexia, vomiting, anddiarrhea
(Figure). Several days later, the clinical
signs worsened. The cat demonstrated sneezing (Video
2; Video 3); a harsh, productive
cough several times a day; episodes of paroxysmal reverse sneezing (Video 4; Video
5); labored breathing with increased respiratory effort and frequency; and
emaciation (Video 6). The clinical impression
at this time was that of a restrictive breathing pattern suggestive of substantial
involvement of parenchyma, pleura, or both. The cat’s condition then gradually
improved; she became less lethargic, vomiting stopped, feces resumed normal consistency,
episodes of cough became less frequent, and appetite quickly improved. The cat recovered
completely within <2 weeks.
Video 1
Cat showing healthy behavior (March 6, 2020). Video
forthcoming
Video 2
Cat showing reverse sneezing, suggestive of the presence of mucous or
mucopurulent material in the throat/nasopharyngeal area (March 16,
2020). Video forthcoming
Video 3
Close-up of cat’s face showing open-mouth breathing, suggesting severe
dyspnea, Video forthcoming nasal/nasopharyngeal obstruction, or
both. The cat appears to be exhausted (March 15, 2020).
Video 4
Cat showing productive cough with terminal retch (March 14, 2020).
Video forthcoming
Video 5
Cat showing productive cough with terminal retch (March 16, 2020).
Video forthcoming
Video 6
Dry and deep cough with terminal retch and restrictive breathing pattern,
suggestive of substantial parenchymal involvement. Cat is emaciated (March
17, 2020). Video forthcoming
Cat showing healthy behavior (March 6, 2020). Video
forthcomingCat showing reverse sneezing, suggestive of the presence of mucous or
mucopurulent material in the throat/nasopharyngeal area (March 16,
2020). Video forthcomingClose-up of cat’s face showing open-mouth breathing, suggesting severe
dyspnea, Video forthcoming nasal/nasopharyngeal obstruction, or
both. The cat appears to be exhausted (March 15, 2020).Cat showing productive cough with terminal retch (March 14, 2020).
Video forthcomingCat showing productive cough with terminal retch (March 16, 2020).
Video forthcomingDry anddeep cough with terminal retch and restrictive breathing pattern,
suggestive of substantial parenchymal involvement. Cat is emaciated (March
17, 2020). Video forthcomingA series of laboratory analyses were then conducted (Appendix). The cat’s owner collected 26 swab samples
according to instructions received by telephone; 16 samples contained varying
amounts of the SARS-CoV-2 genome (Table).
Overall, positive samples were detected March 11–24. The cat was examined by
veterinarians at the time of blood sampling on day 22 after onset of first symptoms.
Clinical examination of the cat was unremarkable at that time, and auscultation of
the thorax revealed no abnormalities. Results of a complete blood count and a serum
biochemistry panel were within reference ranges. Presence of serum IgG was first
sought by Western blotting of mock-exposed andSARS-CoV-2–exposed Vero E6
cells lysates. In convalescent-phase serum, 5 protein bands that were simultaneously
absent from mock-exposed Vero E6 cell lysates were identified (Appendix Figure). Furthermore, the
convalescent-phase serum was positive by double-epitope sandwich ELISA and for 2 of
the 3 antigens tested by double-epitope luciferase assay (Table; Appendix
Table). Whereas serum samples from 30 control cats and 10 control humans were
negative by virus neutralization assay, the convalescent-phase serum samples from
the cat and her owner were positive; endpoints were 1:512 for the cat and 1:128 for
the human.
Table
Severe acute respiratory syndrome coronavirus 2 genome loads measured by
qRT-PCR in a series of consecutive swab samples from cat, Belgium, March
2020*
Date
Oropharyngeal swab samples
Vomitus
Feces
β-actin gene
N gene
β−actin gene
N gene
β-actin gene
N gene
11
NS
NS
26.95
23.5 ± 0.1
35.5
33.3 ± 0.2
12
33.4
38.2 ± 0.5
NS
NS
32.9
34.8 ± 0.0
13
37.8
37.9 ± 0
ND
34.9 ± 0.1
34.4
37,6 ± 0,1
14
25.1
39.3 ± 0.1
NS
NS
30.7
35.1 ± 0.1
15
35.9
35.7 ± 0.1
NS
NS
27.8
33.2 ± 0.1
16
38.2
Negative
NS
NS
26.0
35.1 ± 0
17
27.1
38.2 ± 0
NS
NS
28.7
Negative
18
26.7
Negative
NS
NS
36.1
37.9 ± 0
19
NS
NS
NS
NS
27.9
39.0 ± 0
20
NS
NS
NS
NS
30.1
Negative
21
NS
NS
29.9
33.8 ± 0.1
32.8
Negative
22
37.9
Negative
NS
NS
31.7
Negative
23
NS
NS
NS
NS
33.8
Negative
25
NS
NS
34.9
Negative
35.0
Negative
*Numbers reported
are defined as the number of cycles required for the real-time PCR
assay fluorescent signal curve to intersect with a threshold line
that exceeds background level (mean ± SD). It is a relative
measure of the concentration of the genomic target in the qRT-PCR
reaction (the severe acute respiratory syndrome coronavirus 2 N gene
or cat β-actin gene); values >40 are considered negative.
All samples with qRT-PCR values <40 were analyzed further by a
standard gel RT-PCR targeting the coding sequence of the virus spike
protein gene followed by Sanger sequencing of the correctly sized
amplicon retrieved (»370 bp). Only samples positive for all 3
tests were defined as positive, which was the case for all samples
with a value <40 for the N gene aggregated in this table. NS, no
sample available; negative, RT-qPCR and/or gel PCR and/or sequencing
test failed; qRT-PCR, quantitative reverse transcription PCR.
The cat at first showed general signs, then gastrointestinal signs, and finally
respiratory signs, similar to those observed in humans. Subsequently examined
samples from the cat revealed viral RNA persisting for about 10 days. With the
exception of a vomitus fluid sample collected on March 13, the amounts of viral RNA
were relatively low. For this reason, and despite the simultaneous presence of a
compatible clinical syndrome and a suggestive chronology of events, we cannot
automatically rule out passive contamination of the cat’s samples by its
owner.To confirm the hypothesis of a productive infection of the cat, we conducted a series
of serologic analyses by using 4 different testing approaches and targeting distinct
viral protein targets. All procedures converged toward the same result: the
convalescent-phase serum from the cat contained immunoglobulins against SARS-CoV-2,
which were absent from the serum from control cats. These antibodies target several
distinct viral proteins, and they caused a total neutralizing effect up to a much
higher dilution than those from the owner’s serum. This household cat was
therefore productively infected with the SARS-CoV-2 virus excreted by its owner, and
the infection caused a nonfatal but nevertheless severe disease, mainly of the
respiratory system (Videos 2–6).Public health officials are still learning about SARS-CoV-2, but no current evidence
indicates that pets play a role in spreading the virus. Therefore, taking measures
against companion animals that may compromise their welfare is not justified.
Appendix
Additional materials and methods for study of natural transmission of severe
acute respiratory syndrome coronavirus 2 infection from human to cat,
Belgium, March 2020.
Authors: Christopher M Roundy; Sarah A Hamer; Italo B Zecca; Edward B Davila; Lisa D Auckland; Wendy Tang; Haley Gavranovic; Sonja L Swiger; Jeffery K Tomberlin; Rebecca S B Fischer; Alex Pauvolid-Corrêa; Gabriel L Hamer Journal: J Med Entomol Date: 2022-07-13 Impact factor: 2.435
Authors: Sokani Sánchez-Montes; Gerardo G Ballados-González; Janete Gamboa-Prieto; Anabel Cruz-Romero; Dora Romero-Salas; Carlos D Pérez-Brígido; María J Austria-Ruíz; Alfredo Guerrero-Reyes; Miguel A Lammoglia-Villagómez; Ireri P Camacho-Peralta; José Á Morales-Narcia; José L Bravo-Ramos; Manuel Barrientos-Villeda; Leopoldo A Blanco-Velasco; Ingeborg Becker Journal: Transbound Emerg Dis Date: 2021-06-02 Impact factor: 4.521
Authors: Sarah A Hamer; Alex Pauvolid-Corrêa; Italo B Zecca; Edward Davila; Lisa D Auckland; Christopher M Roundy; Wendy Tang; Mia Kim Torchetti; Mary Lea Killian; Melinda Jenkins-Moore; Katie Mozingo; Yao Akpalu; Ria R Ghai; Jessica R Spengler; Casey Barton Behravesh; Rebecca S B Fischer; Gabriel L Hamer Journal: Viruses Date: 2021-05-19 Impact factor: 5.048